Education
About Us
Working with TipRanks
Follow Us
BUSA - AI Analysis
Top Page
Brandes U.S. Value ETF (BUSA)
Rating:70Outperform
Price Target:
$39.00
Positive Factors
Strong Financial Holdings
Top financial stocks like Citigroup and Wells Fargo have delivered strong year-to-date gains, supporting the ETF's performance.
Sector Diversification
The ETF is spread across ten sectors, reducing the risk of being overly dependent on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid performance so far this year, which may appeal to investors seeking steady growth.
Negative Factors
Underperforming Health Care Stocks
Key health care holdings like Merck and Pfizer have lagged, which could drag on the ETF's overall returns.
High U.S. Concentration
With nearly all assets invested in U.S. companies, the ETF lacks exposure to international markets, limiting geographic diversification.
Moderate Expense Ratio
The fund's expense ratio is higher than some low-cost ETFs, which could eat into long-term returns for investors.
BUSA vs. SPDR S&P 500 ETF (SPY)
AUM254.93M
RegionNorth America
Expense Ratio0.60%
Beta0.76
IssuerBrandes
Inception DateOct 03, 2023
Dividend Yield1.55%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume29,231
30 Day Avg. Volume21,146
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.12Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering63
BUSA Summary
The Brandes U.S. Value ETF (Ticker: BUSA) is an investment fund that focuses on U.S. companies that are considered undervalued, meaning their stock prices are lower than what the fund managers believe they are worth. It includes a mix of industries like healthcare, financials, and technology, with well-known companies such as Merck and Bank of America among its top holdings. Investors might consider BUSA for potential long-term growth by targeting stocks that could rebound in value over time. However, new investors should be aware that the fund’s performance can fluctuate with the overall market, and its focus on undervalued stocks may take time to show results.
How much will it cost me?The Brandes U.S. Value ETF (BUSA) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because it is actively managed, with experts selecting undervalued stocks rather than following a passive index.
What would affect this ETF?The Brandes U.S. Value ETF could benefit from a recovery in undervalued sectors like Financials and Health Care, especially if economic conditions improve or interest rates stabilize, supporting growth in these industries. However, rising interest rates or regulatory changes in key sectors like Technology and Energy could negatively impact some of its top holdings, such as Bank of America and Chevron. The ETF's focus on U.S. equities means it is sensitive to domestic economic trends and policy shifts.
BUSA Top 10 Holdings
The Brandes U.S. Value ETF (BUSA) leans heavily into health care and financials, with Merck and Bank of America among its top holdings. Merck has shown mixed performance, with recent gains offset by year-to-date struggles, while Bank of America is steadily rising thanks to solid earnings despite some short-term headwinds. Chevron adds energy exposure, but its performance has been lukewarm, held back by market volatility. Meanwhile, Alphabet is a bright spot, riding strong revenue growth and AI innovations to lead the pack. Overall, the fund's U.S.-focused value strategy is a bet on long-term recovery for undervalued names.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 2.84% | $7.28M | ― | ― | ― | |
| Bank of America | 2.80% | $7.17M | $395.90B | 27.99% | 66 Neutral | |
| Merck & Company | 2.79% | $7.14M | $214.76B | -15.61% | 79 Outperform | |
| Chevron | 2.74% | $7.01M | $322.91B | 3.04% | 73 Outperform | |
| Citigroup | 2.71% | $6.93M | $186.35B | 58.89% | 67 Neutral | |
| Alphabet Class C | 2.50% | $6.39M | $3.40T | 63.24% | 80 Outperform | |
| Textron | 2.49% | $6.37M | $14.24B | -0.80% | 67 Neutral | |
| Wells Fargo | 2.45% | $6.28M | $278.60B | 34.46% | 66 Neutral | |
| Pfizer | 2.26% | $5.78M | $140.15B | -12.25% | 78 Outperform | |
| Amdocs | 2.24% | $5.75M | $9.27B | -4.32% | 74 Outperform |
BUSA Technical Analysis
Neutral
―
Price Trends
34.72
Negative
34.04
Positive
32.99
Positive
Market Momentum
0.05
Positive
47.45
Neutral
14.18
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BUSA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 34.84, equal to the 50-day MA of 34.72, and equal to the 200-day MA of 32.99, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 47.45 is Neutral, neither overbought nor oversold. The STOCH value of 14.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BUSA.
BUSA Peer Comparison
Comparison Results
Performance Comparison
BUSA
Brandes U.S. Value ETF
34.64
3.53
11.35%
VFVA
Vanguard U.S. Value Factor ETF
―
―
―
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
AIVL
WisdomTree U.S. AI Enhanced Value Fund
―
―
―
GVLU
Gotham 1000 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents